Angelousi, A.; Ziogas, D.C.; Siampanopoulou, V.; Mytareli, C.; Anastasopoulou, A.; Lyrarakis, G.; Gogas, H.
Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria. Diseases 2024, 12, 40.
https://doi.org/10.3390/diseases12020040
AMA Style
Angelousi A, Ziogas DC, Siampanopoulou V, Mytareli C, Anastasopoulou A, Lyrarakis G, Gogas H.
Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria. Diseases. 2024; 12(2):40.
https://doi.org/10.3390/diseases12020040
Chicago/Turabian Style
Angelousi, Anna, Dimitrios C. Ziogas, Vasiliki Siampanopoulou, Chrysoula Mytareli, Amalia Anastasopoulou, George Lyrarakis, and Helen Gogas.
2024. "Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria" Diseases 12, no. 2: 40.
https://doi.org/10.3390/diseases12020040
APA Style
Angelousi, A., Ziogas, D. C., Siampanopoulou, V., Mytareli, C., Anastasopoulou, A., Lyrarakis, G., & Gogas, H.
(2024). Reaching the Diagnosis of Checkpoint Inhibitor-Induced Diabetes Mellitus in Different Clinical Scenarios: A Real-World Application of Updated Diagnostic Criteria. Diseases, 12(2), 40.
https://doi.org/10.3390/diseases12020040
